LAS VEGAS, NV--(NewMediaWire - Mar 1, 2017) - Freedom Leaf,
Inc. (OTC PINK: FRLF) The Marijuana Legalization Company ™
announced today that all of its existing and currently planned US
operations would not be affected by any possible "greater
enforcement " of laws against "recreational" marijuana.
Freedom Leaf CEO Clifford J Perry, explained, "We do not grow or
sell recreational marijuana, so the Trump Administration's vague
threats about "greater enforcement" are not material to our current
business model. Moreover, we are looking abroad for new
opportunities in Europe, Israel, and Latin America.
Also Freedom Leaf's founders, Clifford J Perry and Richard Cowan
will be attending the Barcelona Cannabis Expo, and Perry will also be
attending the CannaTech 2017 conference in Tel Aviv.
CannaTech showcases the full spectrum of global industry leaders,
spanning the fields of science, research, finance, medicine,
government policy, tech innovation, agriculture &
entrepreneurship, at one outstanding event with a singular focus on
cannabis and all the opportunity that surrounds it.
Freedom Leaf already has licensees in Spain and The Netherlands,
and will be expanding its licensing program domestically and to
other countries.
As previously announced, Freedom Leaf has entered into a
Strategic Joint Venture with NuAxon BioScience to distribute their
large capacity supercritical CO2 extraction units. The booming
demand for high grade cannabinoid extracts, such as CBD
(cannabidiol), can only be met with large capacity extraction
devices that are manufactured to maximize efficiency for the
Cannabis and Industrial Hemp sector.
The industrial hemp harvest is expected to dramatically increase
in the US and worldwide. NuAxon BioScience's has 17 years
experience in manufacturing and operating large capacity super
critical CO2 extraction units with their proprietary 5,000 psi pump
that delivers greater economies of scale in the extraction
process.
Freedom Leaf has also entered into a Strategic Joint Venture
distribution agreement with Nisarga Biotech Group of India, for their
US Patent Pending proprietary formulas for Ayurvedic medicine.
Freedom Leaf, Inc. has the exclusive distribution rights for these
formulas, which, combined with CBDs, will create a health enhancing
line of skin care and breathable vapor products.
"Ayurveda" is one of the world's oldest holistic ("whole-body")
healing systems. It was developed more than 3,000 years ago in
India. It is based on the belief that health and wellness depend on
a delicate balance between the mind, body, and spirit. Its main
goal is to promote good health.
As a result of this licensing agreement, Freedom Leaf has
launched a new marketing program with a series of unique
proprietary skin care and herbal vapor products under
the hempOLOGYsm Brand, featuring American grown and
extracted legal hemp CBD (Cannabidiol). These products are being
positioned to expand Freedom Leaf's revenue streams exponentially
by monetizing its publishing and digital marketing platforms in two
of the fastest growing areas of the booming cannabis/hemp
industry.
Also, FLI Agency, Freedom Leaf's in house full
service creative and marketing agency now has direct merchant
banking solutions with a processing company that is successfully
doing business with CBD (cannabidiol) products and Marijuana
dispensaries.
FLI Agency has negotiated broker and agent commission overrides
on the merchant business it secures for the processing companies.
The commission overrides are paid on a residual basis and have the
potential to become a significant revenue source for Freedom Leaf,
Inc.
Safe Harbor Statement
Statements in this press release that are not strictly
historical are "forward-looking" statements within the meaning of
Section 27A of the Securities Act of 1933, as amended and Section
21E of the Securities Exchange Act of 1934, as amended. These
forward-looking statements generally can be identified by phrases
such as Freedom Leaf, Inc. or its management "believes," "expects,"
"anticipates," "foresees," "forecasts," "estimates" or other words
or phrases of similar import. Similarly, statements herein that
describe the Company's business strategy, outlook, objectives,
plans, intentions or goals also are forward-looking statements. All
such forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those in forward-looking statements. Factors that could cause
or contribute to differences include the uncertainty regarding
viability and market acceptance of the Company's products and
services, changes in relationships with third parties, and other
factors described in the Company's most recent periodic filings
with the Securities and Exchange Commission, including its Annual
Report on Form 10-K dated June 30, 2016 and quarterly reports on
Form 10-Q.
Investor relations information can be found on the FreedomLeafInc.com company website.